Hypertension Management Guidelines
Diagnosis and Classification
- The International Society of Hypertension recommends diagnosing hypertension when office blood pressure readings are consistently ≥140/90 mmHg, with confirmation using home or ambulatory blood pressure monitoring 1
- Validated automated upper arm cuff devices with appropriate cuff size should be used, measuring both arms at first visit and subsequently using the arm with higher readings 1, 2
- Home BP readings should be <135/85 mmHg and 24-hour ambulatory BP <130/80 mmHg to be considered normal 2
Treatment Approach
- The International Society of Hypertension guidelines recommend a target blood pressure of <130/80 mmHg for most patients, with lifestyle modifications and drug therapy based on blood pressure levels 1, 2, 3
- Weight reduction to achieve ideal body weight through reduced calorie intake is recommended 4
- Alcohol moderation (≤2 standard drinks/day for men, ≤1 for women) is advised 4
- Immediately start medications in high-risk patients (with cardiovascular disease, chronic kidney disease, diabetes, organ damage, or aged 50-80 years) with BP ≥140/90 mmHg 1, 2
- After 3-6 months of lifestyle intervention, start medications in low-moderate risk patients with persistent BP ≥140/90 mmHg 1, 2, 3
Pharmacological Treatment
- For non-black patients, start with low dose ACE inhibitor (ACEI) or angiotensin receptor blocker (ARB) 1, 2
- For black patients, start with low dose ARB + dihydropyridine CCB or CCB + thiazide/thiazide-like diuretic 1, 2
- Consider spironolactone as fourth-line agent for resistant hypertension 1, 2
Special Populations
- For patients with coronary artery disease, target BP <130/80 mmHg (<140/80 in elderly) and use RAS blockers, beta-blockers with or without CCBs 4
- For patients with previous stroke, target BP <130/80 mmHg (<140/80 in elderly) and use RAS blockers, CCBs, and diuretics 4
- For patients with heart failure, target BP <130/80 mmHg but >120/70 mmHg and use RAS blockers, beta-blockers, and mineralocorticoid receptor antagonists 4
- For patients with chronic kidney disease, target BP depends on proteinuria level and use RAS blockers as first-line 4, 5
- For patients with diabetes, target BP <130/80 mmHg and prefer RAS inhibitors and CCBs 5